1Tristram DA, Welliver RC, Mohar CK, et al. Immunogenicity and safety of respiratory syncytial virus subunit vaccine in sen)positive children 18 to 36 months old. J Infect Dis, 1993, 167: 191-195.
2Tristram DA, WeUiver RC, Hogerman DA, et al. Second-year surveillance of recipients of a respiratory syncytial virus (RSV) F protein subunit vaccine, PFP-1 : Evaluation of antibody persistence and possible disease enhancenmnt. Vaccine, 1994, 12: 551-556.
3Falsey AR, Walsh EE. Safety and immunogenicity of respiratory syncytial virus subunit vaccine(PFP-2)in ambulatory adults over age 60. Vaccine,1996, 14: 1214-1218.
4Munoz FM, Piedra PA, Glezen WP. Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant woman.Vaccine, 2003, 21: 3465-3467.
5Piedra PA, Grace S, Jewell A, et al. Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis. Pediatr Infect Dis J, 1996, 15:23 -31.
6Piedra PA, Cron SG, Jewell A, et al. Immunologenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trail in children with cystic fibrosis. Vaccine, 2003, 21: 2448-2460.
7Groothuis JR, King SJ, Hogerman DA, et al. Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in seropositive children with bronchopulmonary dysplasia. J Infect Dis, 1998, 177:467-469.
8Power UF, Nguyen TN, Rietveld E, et al. Safety and immunogenicity of a novel recombinant submfit respiratory syncytial virus vaccine(BBG2Na)in healthy adults. J Infect Dis, 2001, 184: 1456-1460.
9Plotnicky-Gilquin H, Cyblat-Chanal D, Goetsch L, et al. Passive transfer of serum antibodies induced by BBG2Na, a subunit vaccine, in the elderly protects SCID mouse lungs against respiratory syncytial virus challenge. Virology, 2002, 303: 130-137.
10Hancock GE, Heers KM, Smith JD, et al. CpG containingoligodeoxynucleotides are potent adjuvants for parenteral vaccination with the fusion(F) protein of respiratory syncytial virus(RSV). Vaccine, 2001,19: 4874-4882.
